Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kevin Rubenstein

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Viruses|November 27, 2021
A Comprehensive Coordinator Supported Hepatitis C Virus Testing and Linkage to Treatment Program at Kaiser Permanente Mid-Atlantic StatesMary Cabell Jonas, Kevin Rubenstein, Eric Watson, et al.
Transplantation Proceedings|March 5, 2022
Early Referral, Living Donation, and Preemptive Kidney TransplantAklilu A Yishak, Kevin Rubenstein, Eboni D Clark, et al.
Behavior Genetics|September 21, 2010
Genome scan for spelling deficits: effects of verbal IQ on models of transmission and trait gene localizationKevin Rubenstein, Mark Matsushita, Virginia W Berninger, et al.
Statistics in Medicine|June 11, 2025
Futility Monitoring in Clinical TrialsAna M Ortega-Villa, Megan C Grieco, Kevin Rubenstein, et al.
The Permanente Journal|March 29, 2022
Life Expectancy Trends Among Integrated Health Care System Enrollees, 2014-2017Tori Finch, M Cabell Jonas, Kevin Rubenstein, et al.
IJID Regions|July 24, 2024
Prospective cohort study of patient demographics, viral agents, seasonality, and outcomes of influenza-like illness in Mexico in the late H1N1-pandemic and post-pandemic years (2010-2014)Arturo Galindo-Fraga, Paola Del Carmen Guerra-de-Blas, Ana A Ortiz-Hernández, et al.
The Journal of Infectious Diseases|April 24, 2024
SARS-CoV-2 RNA and Nucleocapsid Antigen Are Blood Biomarkers Associated With Severe Disease Outcomes That Improve in Response to RemdesivirKanal Singh, Kevin Rubenstein, Viviane Callier, et al.
Annals of Internal Medicine|November 28, 2022
Temporal Improvements in COVID-19 Outcomes for Hospitalized Adults: A Post Hoc Observational Study of Remdesivir Group Participants in the Adaptive COVID-19 Treatment TrialGail E Potter, Tyler Bonnett, Kevin Rubenstein, et al.
Plos One|November 14, 2024
Correction: Design of an observational multi-country cohort study to assess immunogenicity of multiple vaccine platforms (InVITE)Irini Sereti, Kathryn Shaw-Saliba, Lori E Dodd, et al.
The New England Journal of Medicine|April 16, 2025
Tecovirimat for Clade I MPXV Infection in the Democratic Republic of Congo, Rosine Ali, Jules Alonga, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Viruses|November 27, 2021
A Comprehensive Coordinator Supported Hepatitis C Virus Testing and Linkage to Treatment Program at Kaiser Permanente Mid-Atlantic StatesMary Cabell Jonas, Kevin Rubenstein, Eric Watson, et al.
Transplantation Proceedings|March 5, 2022
Early Referral, Living Donation, and Preemptive Kidney TransplantAklilu A Yishak, Kevin Rubenstein, Eboni D Clark, et al.
Behavior Genetics|September 21, 2010
Genome scan for spelling deficits: effects of verbal IQ on models of transmission and trait gene localizationKevin Rubenstein, Mark Matsushita, Virginia W Berninger, et al.
Statistics in Medicine|June 11, 2025
Futility Monitoring in Clinical TrialsAna M Ortega-Villa, Megan C Grieco, Kevin Rubenstein, et al.
The Permanente Journal|March 29, 2022
Life Expectancy Trends Among Integrated Health Care System Enrollees, 2014-2017Tori Finch, M Cabell Jonas, Kevin Rubenstein, et al.
IJID Regions|July 24, 2024
Prospective cohort study of patient demographics, viral agents, seasonality, and outcomes of influenza-like illness in Mexico in the late H1N1-pandemic and post-pandemic years (2010-2014)Arturo Galindo-Fraga, Paola Del Carmen Guerra-de-Blas, Ana A Ortiz-Hernández, et al.
The Journal of Infectious Diseases|April 24, 2024
SARS-CoV-2 RNA and Nucleocapsid Antigen Are Blood Biomarkers Associated With Severe Disease Outcomes That Improve in Response to RemdesivirKanal Singh, Kevin Rubenstein, Viviane Callier, et al.
Annals of Internal Medicine|November 28, 2022
Temporal Improvements in COVID-19 Outcomes for Hospitalized Adults: A Post Hoc Observational Study of Remdesivir Group Participants in the Adaptive COVID-19 Treatment TrialGail E Potter, Tyler Bonnett, Kevin Rubenstein, et al.
Plos One|November 14, 2024
Correction: Design of an observational multi-country cohort study to assess immunogenicity of multiple vaccine platforms (InVITE)Irini Sereti, Kathryn Shaw-Saliba, Lori E Dodd, et al.
The New England Journal of Medicine|April 16, 2025
Tecovirimat for Clade I MPXV Infection in the Democratic Republic of Congo, Rosine Ali, Jules Alonga, et al.
Pageof 2